About April Eichler, MD

Departments, Centers, & Programs:

Clinical Interests:



Mass General Cancer Center in Danvers
102 Endicott St.
Danvers, MA 01923
Phone: 978-882-6060

Mass General Cancer Center: Neuro-Oncology
55 Fruit St.
Yawkey Center for Outpatient Care
Boston, MA 02114
Phone: 617-726-5130

Medical Education

  • MD, University of Pittsburgh School of Medicine
  • Residency, Brigham and Women's Hospital
  • Residency, Massachusetts General Hospital
  • Fellowship, Brigham and Women's Hospital
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Neurology, American Board of Psychiatry and Neurology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


As a clinician and researcher in Neuro-Oncology my focus is on the care of patients with brain metastases and neurological complications of cancer and chemotherapy, as well as primary brain tumors. I have established a Multidisciplinary Clinic for Central Nervous System (CNS) Metastases at the Massachusetts General Hospital Cancer Center. The aim of this clinic is to offer interdisciplinary expertise to patients with brain metastases incorporating radiation therapy as well as surgical and medical approaches. The staff therefore encompasses a radiation oncologist as well as a neurosurgeon and draws from a wide patient population at MGH. The joint clinic allows for evaluation and coordinated care of patients with complex needs and morbidities and represents a unique referral center within the New England area.

As part of the mission of the CNS Metastasis clinic, I am committed to developing clinical trials testing novel chemotherapeutics and molecular targeted agents in patients with brain metastases from a variety of primary tumor types. I am the PI on a recently NIH-funded Phase I/II trial of an angiogenesis inhibitor given together with radiation therapy in patients with brain metastases from non-small cell lung cancer. I also serve as the MGH site PI on two multicenter phase II studies for recurrent brain metastases in patients with lung and breast cancer.


Reviews: Comments and Ratings